Cortendo AB
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Cortendo AB sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Cortendo AB: 6 sponsored US clinical trials, none currently recruiting.
Cortendo AB sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. 3 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Endogenous Cushing's Syndrome, with 2 trials.
Upper-quartile sponsor footprint
Cortendo AB sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
6 total, page 1 of 1
Bioavailability of Levoketoconazole and Ketoconazole Tablets
NCT04212000
Drug Interaction Study of Levoketoconazole and Metformin
NCT03880825
Open-label Treatment in Cushing's Syndrome
NCT03621280
Levoketoconazole Food Effect Study in Healthy Subjects
NCT03768388
A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome.
NCT03277690
Treatment for Endogenous Cushing's Syndrome
NCT01838551
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 3 | 3 |
Therapeutic Areas
How the Cortendo AB archive is shaped
6 indexed studies, none listed as recruiting (0% open); 6 completed (100%).
Phase mix: 3 late (III/IV) vs 3 early (I/II) (balanced across stages).
Top condition: Endogenous Cushing's Syndrome (2 trials), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Cortendo AB: archived-pipeline peers nationwide
Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Cortendo AB sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 archived trials
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
Related
What to do with this Cortendo AB page
6 registered trials is a research-attention snapshot, not an endorsement of Cortendo AB or any single study.
- None of Cortendo AB's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Endogenous Cushing's Syndrome is the condition Cortendo AB studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Endogenous Cushing's Syndrome trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Cortendo AB pipeline card: 6 registered trials from official public datasets.Report a data error.